查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946626

2026年全球新型藥物遞送系統市場報告

Novel Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，新型藥物遞送系統的市場規模迅速擴張，預計將從2025年的1,176.6億美元成長到2026年的1,294.5億美元，複合年成長率達10.0%。過去幾年的成長可歸因於慢性病盛行率的上升、傳統藥物遞送方法的局限性、腫瘤和生物製藥研發管線的擴展、醫療保健成本的上漲以及聚合物和奈米技術的進步。

預計未來幾年，新型藥物遞送系統市場將維持強勁成長，2030年市場規模將達到1,875.3億美元，複合年成長率（CAGR）為9.7%。預測期內的成長主要受以下因素驅動：個人化和精準醫療的蓬勃發展、標靶癌症治療需求的成長、藥物研發投入的增加、生物製劑和生物相似藥的擴張，以及監管機構對先進藥物遞送技術的支持。預測期內的關鍵趨勢包括：標靶化和個人化藥物遞送的擴展、脂質和聚合物奈米顆粒應用的日益普及、緩釋製劑的成長、對非侵入性和以患者為中心的給藥途徑的日益關注，以及組合式和混合式新型藥物遞送系統（NDDS）平台研發的加速。

神經系統疾病發生率的不斷上升預計將推動新型藥物遞送系統市場的成長。神經系統疾病，例如中風，其特徵是由於腦部血流中斷而導致的神經功能突然喪失。這可能是由血管阻塞（缺血性中風）或血管破裂（出血性中風）引起的，並可能導致腦損傷以及認知、感覺和運動定向的長期損害。導致神經系統疾病發生率上升的因素包括血腦障壁老化、高血壓、糖尿病和肥胖等文明病疾病的增加，以及慢性壓力和環境風險的增加。新型藥物遞送系統可以透過實現標靶和可控的藥物遞送，幫助治療這些疾病。例如，根據英國國家醫療服務體系（NHS）2024年11月發布的數據，2023/24年度英格蘭地區因中風住院的患者人數將達到111,137人，其中50-59歲年齡層的增幅最為顯著，新增病例達12,533例。神經系統疾病發生率的上升正在推動新型藥物輸送系統市場的成長。

新型藥物遞送系統市場的主要企業正透過口腔薄膜等產品進行創新，以提高患者依從性和治療效果。口腔薄膜是一種快速溶解的貼片，貼於口腔內，透過黏膜層將藥物直接輸送到血液中。例如，2024年2月，美國製劑研發公司CD Formulation推出了其「口腔薄膜技術」。該技術能夠繞過消化道和肝臟的代謝，使藥物快速吸收，非常適合吞嚥困難的患者。此外，它還能達到精準的劑量控制和更短的起效時間，進而提高各種治療方法的治療精準性和便利性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球新型藥物遞送系統市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 擴大標靶化和個人化藥物遞送
    • 脂質和聚合物奈米粒子的應用日益廣泛
    • 緩釋製劑的成長
    • 越來越重視非侵入性和以病人為中心的治療途徑
    • 加速組合式與混合式NDD平台的研究與開發

第5章 終端用戶產業市場分析

  • 醫院
  • 專科診所
  • 製藥公司
  • 生技公司
  • 研究中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球新型藥物遞送系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球新型藥物遞送系統市場規模、比較及成長率分析
  • 全球新型藥物遞送系統市場表現：規模與成長，2020-2025年
  • 全球新型藥物遞送系統市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依配方類型
  • 脂質體、奈米顆粒、微球、水凝膠、樹狀聚合物
  • 新型藥物遞送系統（NDDS）依模式
  • 標靶藥物遞送系統、控釋藥物遞送系統、調節藥物傳遞系統
  • 沿途
  • 口服給藥系統、注射給藥系統、肺部給藥系統、經皮給藥系統、其他給藥途徑
  • 透過癒合區域
  • 癌症、心血管疾病、神經系統疾病、感染疾病、自體免疫疾病
  • 最終用戶
  • 醫院、專科診所、研究中心和其他最終用戶
  • 按類型細分：脂質體
  • 聚乙二醇化脂質體、陽離子脂質體、隱形脂質體、免疫脂質體
  • 按類型細分：奈米顆粒
  • 聚合物奈米顆粒、脂質奈米顆粒、金屬奈米顆粒、奈米晶體
  • 按類型細分：微球
  • 可生物分解微球、磁性微球、放射性微球、黏膜黏附微球
  • 按類型細分：水凝膠
  • 熱敏水凝膠、pH響應水凝膠、注射型水凝膠、智慧水凝膠
  • 按類型細分：樹狀聚合物
  • PAMAM樹狀聚合物、PPI樹狀聚合物、PEG化樹狀樹狀聚合物、雜化樹狀聚合物

第10章 區域與國家分析

  • 全球新型藥物遞送系統市場：區域分析、預測與趨勢（2020-2025年、2025-2030年預測、2035年預測）
  • 全球新型藥物遞送系統市場：國家/地區、市場表現及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 新型藥物遞送系統市場：競爭格局及市場佔有率（2024年）
  • 新型藥物遞送系統市場：公司估值矩陣
  • 新型藥物遞送系統市場：公司概況
    • Pfizer Inc
    • Johnson And Johnson
    • F Hoffmann La Roche AG
    • Merck And Co Inc
    • AbbVie Inc

第37章：其他領先和創新企業

  • Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年新型藥物輸送系統市場：提供新機會的國家
  • 2030年新型藥物輸送系統市場：蘊藏新機會的細分市場
  • 2030年新型藥物輸送系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MNDDS01_G26Q1

Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.

Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.

Tariffs have influenced the novel drug delivery systems market by increasing costs for imported raw materials such as polymers, lipids, and specialized nanoparticles, impacting overall manufacturing economics and pricing strategies. these effects are most pronounced in formulation types like liposomes and nanoparticles and across regions reliant on cross-border pharmaceutical supply chains, particularly asia-pacific and europe. however, tariffs are also encouraging localization of manufacturing, regional supply chain diversification, and domestic innovation, which may strengthen long-term market resilience and self-sufficiency.

The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $117.66 billion in 2025 to $129.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, limitations of conventional drug delivery methods, growth in oncology and biologics pipeline, rising healthcare expenditure, advancements in polymer and nanotechnology.

The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $187.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to surge in personalized and precision medicine, growing demand for targeted cancer therapies, increasing investment in pharmaceutical r&d, expansion of biologics and biosimilars, regulatory support for advanced drug delivery technologies. Major trends in the forecast period include expansion of targeted and personalized drug delivery, rising adoption of lipid and polymeric nanoparticles, growth in long-acting and controlled release formulations, increased focus on non-invasive and patient-centric delivery routes, accelerated r&d in combination and hybrid ndds platforms.

The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.

Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.

Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG

North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Novel Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
  • 2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
  • 3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
  • 4) By Therapeutic Area: Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases
  • 5) By End-User: Hospital; Specialty Clinics; Research Centers; Other End-Users
  • Subsegments:
  • 1) By Liposomes: PEGylated Liposomes; Cationic Liposomes; Stealth Liposomes; Immunoliposomes
  • 2) By Nanoparticles: Polymeric Nanoparticles; Lipid Nanoparticles; Metallic Nanoparticles; Nanocrystals
  • 3) By Microspheres: Biodegradable Microspheres; Magnetic Microspheres; Radioactive Microspheres; Mucoadhesive Microspheres
  • 4) By Hydrogels: Thermosensitive Hydrogels; Ph-Responsive Hydrogels; Injectable Hydrogels; Smart Hydrogels
  • 5) By Dendrimers: PAMAM Dendrimers; PPI Dendrimers; Pegylated Dendrimers; Hybrid Dendrimers
  • Companies Mentioned: Pfizer Inc; Johnson And Johnson; F Hoffmann La Roche AG; Merck And Co Inc; AbbVie Inc; Bayer AG; Sanofi SA; Bristol Myers Squibb Company; AstraZeneca PLC; Novartis AG; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; Eli Lilly And Company; Gilead Sciences; Amgen Inc; Teva Pharmaceutical Industries Ltd; Otsuka Pharmaceutical Co Ltd; Regeneron Pharmaceuticals; Samyang Holdings Corporation; Galen Limited; Catalent Inc; Evonik Industries AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Novel Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Novel Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Novel Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Novel Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Targeted And Personalized Drug Delivery
    • 4.2.2 Rising Adoption Of Lipid And Polymeric Nanoparticles
    • 4.2.3 Growth In Long-Acting And Controlled Release Formulations
    • 4.2.4 Increased Focus On Non-Invasive And Patient-Centric Delivery Routes
    • 4.2.5 Accelerated R&D In Combination And Hybrid Ndds Platforms

5. Novel Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Research Centers

6. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Novel Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Novel Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Novel Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Novel Drug Delivery Systems Market Segmentation

  • 9.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
  • 9.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
  • 9.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
  • 9.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
  • 9.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Specialty Clinics, Research Centers, Other End-Users
  • 9.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes
  • 9.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals
  • 9.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres
  • 9.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels
  • 9.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers

10. Novel Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Novel Drug Delivery Systems Market

  • 11.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Novel Drug Delivery Systems Market

  • 12.1. China Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Novel Drug Delivery Systems Market

  • 13.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Novel Drug Delivery Systems Market

  • 14.1. Japan Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Novel Drug Delivery Systems Market

  • 15.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Novel Drug Delivery Systems Market

  • 16.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Novel Drug Delivery Systems Market

  • 17.1. South Korea Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Novel Drug Delivery Systems Market

  • 18.1. Taiwan Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Novel Drug Delivery Systems Market

  • 19.1. South East Asia Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Novel Drug Delivery Systems Market

  • 20.1. Western Europe Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Novel Drug Delivery Systems Market

  • 21.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Novel Drug Delivery Systems Market

  • 22.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Novel Drug Delivery Systems Market

  • 23.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Novel Drug Delivery Systems Market

  • 24.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Novel Drug Delivery Systems Market

  • 25.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Novel Drug Delivery Systems Market

  • 26.1. Eastern Europe Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Novel Drug Delivery Systems Market

  • 27.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Novel Drug Delivery Systems Market

  • 28.1. North America Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Novel Drug Delivery Systems Market

  • 29.1. USA Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Novel Drug Delivery Systems Market

  • 30.1. Canada Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Novel Drug Delivery Systems Market

  • 31.1. South America Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Novel Drug Delivery Systems Market

  • 32.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Novel Drug Delivery Systems Market

  • 33.1. Middle East Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Novel Drug Delivery Systems Market

  • 34.1. Africa Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Novel Drug Delivery Systems Market Regulatory and Investment Landscape

36. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Novel Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Novel Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Novel Drug Delivery Systems Market Company Profiles
    • 36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

37. Novel Drug Delivery Systems Market Other Major And Innovative Companies

  • Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited

38. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market

40. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Novel Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Novel Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Novel Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer